Systematic review shows varied response rates to pharmacological treatment in social anxiety disorder, implying a need for personalized approaches.
When CBT is unavailable, SSRIs are the first-line pharmacological treatment for SAD based on current evidence. However, response rates vary substantially. We recommend a personalized approach that includes patient preference and treatment accessibility.
No takes yet. Share an insight, caveat, or question.
Andreoli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: